Genialis Presents ResponderID KRAS, a Biomarker Framework for Predicting Patient Response
Genialis points ResponderID, its innovative biomarker framework combining machine learning and RNA-sequencing, at the challenge of KRAS inhibition BOSTON, MA, USA, September 27, 2023 /EINPresswire.com/ -- Genialis, the RNA-biomarker company, today …